{"id":30801,"date":"2017-04-14T11:04:58","date_gmt":"2017-04-14T09:04:58","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=30801"},"modified":"2017-04-30T09:41:18","modified_gmt":"2017-04-30T07:41:18","slug":"regione-90-riduzione-sul-costo-dei-farmaci-antitumorali","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/regione-90-riduzione-sul-costo-dei-farmaci-antitumorali\/","title":{"rendered":"Piedmont Region: 90% reduction on the cost of anticancer drugs"},"content":{"rendered":"<p>The Piedmont Region achieved savings of more than \u20ac10 million a year on the cancer drug Imatinib thanks to a reduction in the original price of 90%. Cost reduction is <img loading=\"lazy\" decoding=\"async\" class=\"alignright\" src=\"http:\/\/104.155.77.98\/quellichelafarmacia\/wp-content\/uploads\/sites\/5\/2016\/02\/308022015212905_saitta.jpg\" alt=\"Risultati immagini per saitta piemonte\" width=\"175\" height=\"174\" \/>which took place through the tender announced by Scr Piemonte and awarded in recent days.<\/p>\n<p>Until 2016, the medicine was covered by a patent, since January the corresponding equivalent products have entered the market.<\/p>\n<p>\u201cWe are satisfied with the outcome of this tender, which allows us to continue to guarantee the health of citizens but achieving considerable savings and therefore freeing up useful resources to strengthen our health care \u2013 underlines the regional health councilor Antonio Saitta -. This is an example of how pharmaceutical tenders represent a great opportunity for the healthcare system&quot;.<\/p>\n<p class=\"al_buttons_container\">\u00a0<a href=\"http:\/\/www.vcoazzurratv.it\/regionali\/4641-regione-90-di-riduzione-sul-costo-dei-farmaci-antitumorali\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"color: #0000ff;\">14th April 2017 \u2013 Azzurra TV<\/span><\/a><\/p>\n<p class=\"al_buttons_container\">Related news: <span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"http:\/\/www.fedaiisf.it\/en\/il-piemonte-mi-nega-la-cura-che-mi-salverebbe-la-vita-lappello-di-un-malato-di-tumore\/\" target=\"_blank\" rel=\"noopener noreferrer\">&quot;Piedmont denies me the treatment that would save my life&quot;: the appeal of a cancer patient<\/a><\/span><\/p>\n<p><a href=\"http:\/\/www.tvsvizzera.it\/tvs\/tutte-le-notizie-in-breve\/times-contro-big-pharma---piano-tagli-farmaci-anticancro-\/43110882\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"color: #0000ff;\">Times against Big Pharma, &#039;plan to cut cancer drugs&#039;<\/span><\/a><\/p>\n<div class=\"al_buttons_container\"><\/div>","protected":false},"excerpt":{"rendered":"<p>La Regione Piemonte ha ottenuto un risparmio superiore ai 10 milioni di euro l\u2019anno sul farmaco antitumorale Imatinib grazie a un ribasso del prezzo originale del 90%. La riduzione del costo \u00e8 avvenuta attraverso la gara bandita da Scr Piemonte e aggiudicata nei giorni scorsi. Fino al 2016 il medicinale era coperto da brevetto, da &hellip;<\/p>","protected":false},"author":4,"featured_media":30802,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[29,79],"class_list":["post-30801","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-prezzo-farmaci","tag-ssn"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/30801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=30801"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/30801\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/30802"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=30801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=30801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=30801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}